Evaluation of lipoprotein-associated phospholipase A2 levels in association with carotid atherosclerosis in patients with coronary artery disease

被引：0
|
作者：
Osmankulova, G. [1 ]
Kurmanbekova, B. T. [1 ]
Noruzbaeva, A. M. [1 ]
机构：
[1] Natl Ctr Cardiol & Therapy, Bishkek, Kyrgyzstan
来源：
EUROPEAN HEART JOURNAL | 2017年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P893
引用
收藏
页码：199 / 200
页数：2
相关论文
共 50 条
  • [1] Lipoprotein-associated Phospholipase A2 in Coronary Artery Disease
    Dimitroglou, Yannis
    Sakalidis, Athanasios
    Mavroudis, Andreas
    Kalantzis, Charalambos
    Valatsou, Angeliki
    Andrikou, Ioannis
    Christofi, Angela
    Mantzouranis, Emmanouil
    Kachrimanidis, Ioannis
    Bei, Evellina
    Lazarou, Emilia
    Tsioufis, Costas
    Tousoulis, Dimitris
    Lazaros, George
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2022, 22 (28) : 2344 - 2354
  • [2] Lipoprotein-associated Phospholipase A2 Levels Are Associated With Vascular Function in Patients With Coronary Artery Disease
    Siasos, Gerasimos
    Oikonomou, Evangelos
    Zaromitidou, Marina
    Mourouzis, Kostas
    Miliou, Antigoni
    Georgiopoulos, Georgios
    Antonopoulos, Alexis
    Papamikroulis, Georgios Angelos
    Vogiatzi, Georgia
    Tsalamandris, Sotirios
    Vavuranakis, Manolis
    Tousoulis, Dimitris
    CIRCULATION, 2016, 134
  • [3] Lipoprotein-associated phospholipase A2 and atherosclerosis
    Wilensky, Robert L.
    Macphee, Colin H.
    CURRENT OPINION IN LIPIDOLOGY, 2009, 20 (05) : 415 - 420
  • [4] Lipoprotein-associated phospholipase A2 levels in the coronary circulation are associated with early coronary atherosclerosis in humans
    Lavi, Shahar
    Rihal, Charanjit S.
    Prasad, Abhiram
    Mathew, Verghese
    Barsness, Gregory W.
    McConnell, Joseph P.
    Lerman, Lilach O.
    Lerman, Amir
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 214M - 214M
  • [5] Higher lipoprotein-associated phospholipase A2 levels are associated with coronary atherosclerosis documented by coronary angiography
    Dohi, Tomotaka
    Miyauchi, Katsumi
    Ohkawa, Ryunosuke
    Nakamura, Kazuhiro
    Thuboi, Shuta
    Ogita, Manabu
    Miyazaki, Tadashi
    Nishino, Akihisa
    Yokoyama, Ken
    Kurata, Takeshi
    Yatomi, Yutaka
    Daida, Hiroyuki
    ANNALS OF CLINICAL BIOCHEMISTRY, 2012, 49 : 527 - 533
  • [6] Lipoprotein-associated phospholipase A2 levels are associated with erectile dysfunction in patients without known coronary artery disease
    Otunctemur, A.
    Sahin, S.
    Ozbek, E.
    Cekmen, M.
    Inal, A.
    Tulubas, F.
    Dursun, M.
    Besiroglu, H.
    Koklu, I.
    ANDROLOGIA, 2015, 47 (06) : 706 - 710
  • [7] Plasma Lipoprotein-associated Phospholipase A2 in Patients with Metabolic Syndrome and Carotid Atherosclerosis
    Gong, Hui-ping
    Du, Yi-meng
    Zhong, Li-na
    Dong, Zhao-qiang
    Wang, Xin
    Mao, Yong-jun
    Lu, Qing-hua
    LIPIDS IN HEALTH AND DISEASE, 2011, 10
  • [8] Plasma Lipoprotein-associated Phospholipase A2 in Patients with Metabolic Syndrome and Carotid Atherosclerosis
    Hui-ping Gong
    Yi-meng Du
    Li-na Zhong
    Zhao-qiang Dong
    Xin Wang
    Yong-jun Mao
    Qing-hua Lu
    Lipids in Health and Disease, 10
  • [9] Darapladib, a reversible lipoprotein-associated phospholipase A2 inhibitor, for the oral treatment of atherosclerosis and coronary artery disease
    Riley, Robert F.
    Corson, Marshall A.
    IDRUGS, 2009, 12 (10) : 648 - 655
  • [10] Association of Lipoprotein-Associated Phospholipase A2 with Coronary Artery Disease in African-Americans and Caucasians
    Anuurad, Erdembileg
    Ozturk, Zeynep
    Enkhmaa, Byambaa
    Pearson, Thomas A.
    Berglund, Lars
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (05): : 2376 - 2383
12345